We run Clinical trials for patients with Chronic Kidney Disease and those on dialysis. Trials take place in Aintree, Southport and Waterloo.
Current studies:
A study to evaluate the effect of Sodium Zirconium Cyclosilicate on Arrhythmia related cardiovascular outcomes in dialysis patients with hyperkalaemia.
A study of the Efficacy and Safety of Sparsentan for the treatment of Immunoglobulin A Nephropathy.
A trial of Empagliflozin to assess cardio-renal outcomes in patients with CKD.
Survival Improvement with Colecalciferol in patients on dialysis.
Aldosterone Blockade for Health Improvement Evaluation in End Stage Renal Disease.
Dialysis Outcomes and Practice Patterns Study.
Prospective observational study for patients with CKD and a diagnosis of Calciphylaxis.
A national registry of rare kidney diseases.
Contact us
Call Samantha Hope and Lini Kurian on 0151 529 5814.